This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (4)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Fact or Fancy?

Paul A. Bunn, Jr, MD

Arch Dermatol. 1995;131(5):603-605.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

MYCOSIS FUNGOIDES (MF) and the Sézary syndrome (SS) are low-grade non-Hodgkin's lymphomas of helper T-Cell derivation.¹. The term cutaneous T-cell lymphoma (CTCL) is often applied to these two conditions alone, but CTCL is also used to refer to any T-cell lymphoma in the skin, including intermediate and high-grade lymphomas such as peripheral T-cell lymphoma and adult T-cell leukemia/ lymphoma. With the exception of a small minority of stage IA cases, the low-grade lymphomas MF and SS are not curable with conventional therapy.^2-6 Thus, the goal of treatment is palliation. While nearly all patients with MF and SS have symptoms from their skin lesions, there are many effective means of treating the skin, including irradiation therapy (especially electron beam),² topical chemotherapy (especially nitrogen mustard),³ and photochemotherapy with psoralen plus UV light (PUVA).⁴ Unfortunately, most patients will eventually either fail to respond to these topical modalities or . . . [Full Text PDF of this Article]

Author Affiliations
University of Colorado Cancer Center 4200 E Ninth Ave Box B-188 Denver, CO 80262

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?